FORE Biotherapeutics vs Quris
FORE Biotherapeutics vs Quris, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: FORE Biotherapeutics is on 56/100 and Quris on 59/100.
Where each one leads
FORE Biotherapeutics
- headcount growth: +8.2% against +2.1%
- funding raised: $232M against $37.0M
Quris
- our overall score: 59/100 against 56/100
- agent readiness: 52/100 against 37/100
At a glance
| Measure | FORE Biotherapeutics | Quris |
|---|---|---|
| What it is | Precision oncology company developing cancer therapies guided by proprietary functional genomics. | AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures. |
| Category | Healthcare, Drug Development, Genomics, Next Generation Sequencing | Healthcare, Drug Development, Life Sciences, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2011 | 2019 |
| Headquarters | Philadelphia, United States | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | FORE Biotherapeutics | Quris |
|---|---|---|
| Employees | 56 | 45 |
| Headcount growthLast 12 months | +8.2% | +2.1% |
| Total funding | $232M | $37.0M |
| Latest round | Series D-2 Extension | Seed |
| Valuation | $75.0M | Not published |
| LinkedIn followers | 4,584 | 4,239 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | FORE Biotherapeutics | Quris |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 56/100 | 59/100 |
| Traction | 58/100 | 54/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 38/100 | 34/100 |
| Quality | 55/100 | 62/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (37/100) | D (52/100) |
| Domain ratingLink authority, 0-100 | 33/100 | 35/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | FORE Biotherapeutics | Quris |
|---|---|---|
| Hosting | Not detected | Google Cloud |
| CMS | WordPress | Wix |
| Frameworks | Jquery | Not detected |
| Analytics | Not detected | Google Analytics 4 |
FORE Biotherapeutics vs Quris: common questions
Which is better, FORE Biotherapeutics or Quris?
On our 0-100 score Quris rates higher (59/100 against 56/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do FORE Biotherapeutics and Quris compare on the numbers?
FORE Biotherapeutics leads on headcount growth (+8.2% against +2.1%), funding raised ($232M against $37.0M). Quris leads on our overall score (59/100 against 56/100), agent readiness (52/100 against 37/100).
Read the full FORE Biotherapeutics review and pricing or the Quris review and pricing. You can also browse other FORE Biotherapeutics alternatives we track.